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Introduction 
Patients with insomnia commonly present to general practice. Hypnotic misuse and underuse of psychological 
treatments demonstrates scope for improved care. To explore this, we undertook a feasibility study using a 
Quality Improvement Collaborative (QIC) across 8 general practices, investigating the effect of implementing sleep 
assessment and psychological interventions on hypnotic prescribing. 
 
Methods 
We used a before-after analysis of the time series of prescribing of benzodiazepines (e.g. diazepam, temazepam, 
lorazepam) and Z-drugs (e.g. zopiclone, zolpidem, zaleplon) across intervention practices. We contrasted results 
with those for 8 control practices not subject to the QIC. Data were constructed as average daily quantity of 
hypnotic prescribed per Specific Therapeutic group Age-sex weightings Related Prescribing Unit (STAR–PU) for the 
period October 2005 to March 2010. Modelling was by 2-segment intercept-trend regression performed on the 
24 month periods either side of the 6-month operation of the QIC (October 2007 to March 2008). Estimation was 
by either least squares or corrected using the Prais-Winsten method if error serial correlation was present in the 
errors. We then jointly re-estimated across all intervention practices (repeated on all control practices) using 
seemingly unrelated regressions to allow for any potential correlations in the models’ errors. Testing whether the 
intervention had been successful in inducing a structural break such that post-QIC prescribing of either drug was 
reduced, we constructed a bespoke test S based on the mean prediction error in the post-QIC period for 
aggregated intervention practices. 
 
Results 
Comparing the two prescribing periods, there was a noteworthy and significant reduction in benzodiazepine 
prescribing in intervention practices over the shorter post-QIC term of 12 months (S=-2.46, p=0.007), but this was 
not sustained for the full 24 months post-QIC (S=-0.72, p=0.236). However, for Z-drugs prescribing reductions in 
intervention practices were sustained into the longer post-QIC period (12 months: S=-1.98, p=0.024; 24 months, 
S=-1.90, p=0.029). The before-after comparison to control practices showed no significant reduction in prescribing 
of either drug. 
 
Conclusion 
Efficacy of the QIC in reducing hypnotic prescribing was shown, giving support to the need for a full scale trial. 
Varying length of persistence of outcomes warrants attention. 
 
